Read articles from United States of America

November 03, 2022 by acsh.org

For many years, the science communication landscape looked something like this: reputable universities and public health institutions did sound research and educated consumers about the risks they faced; devious activist groups fabricated health scares that gullible and dishonest reporters uncritically amplified; ACSH and other science-minded organizations refuted the nonsense emanating from the headlines.

Things are different today. Often times its reputable healthcare providers and other trusted institutions that mislead consumers. There is no better example than this recent piece published by the Cleveland Clinic: How Vaping or Smoking Impacts Your Physical Activity:

November 02, 2022 by youtube.com

Regulators and government have created a “chaotic hot mess” in the U.S., says Clive Bates, tobacco control policy expert and former Director of Action on Smoking and Health (UK), in today’s episode of RegWatch. Hear Bates break down the 2022 NYTS youth vaping stats, his call for the CDC to stop its dishonest spin of youth vaping data, and his assessment of the FDA’s failed “authorization regime.”

October 31, 2022 by heart.org

Adults who regularly used electronic nicotine delivery devices, or e-cigarettes, displayed worrisome changes in heart and blood vessel function and performed significantly worse on exercise stress testing than people who did not use any nicotine products, according to two separate analyses of preliminary research to be presented at the American Heart Association’s Scientific Sessions 2022. [...] Researchers from the Cardiac and LUng E-cig Smoking (CLUES) Study will present two abstracts that compared outcomes among people who vaped, those who smoked traditional, combustible cigarettes and people who reported not using any nicotine products.

October 27, 2022 by usatoday.com

The Food and Drug Administration on Wednesday rejected a company's application to sell menthol-flavored vaping products, citing a lack of public health benefit and potential risk to youth vapers.

The FDA said Logic Technology Development didn't show its menthol products are more likely than non-flavored products to help people quit or reduce smoking. Combined with the risk of enticing youth vapers who like menthol vapes, the agency rejected the company's marketing of Logic Pro and Logic Power menthol e-liquid packages.

October 25, 2022 by filtermag.org

On October 21, Juul Labs published its administrative appeal of the marketing denial order (MDO) issued by the Food and Drug Administration at the end of June 2022. The move, and Juul’s decision to make it public, reflects the company’s apparent offensive pivot from its longstanding defensive strategy. It calls into question the decision made by the FDA’s Center for Tobacco Products (CTP)—which Juul maintains came from an incorrect and incomplete assessment of its data, leading to an insufficient review of its premarket tobacco product applications (PMTAs).

October 24, 2022 by regulatorwatch.com

The War on Vaping continues unabated, as the U.S. Centers for Disease Control states in a group call with anti-vaping lobbyists that the teen vaping “epidemic” is NOT over.
And the FDA digs in, refusing to set the record straight with the American public over the perceived risks and harms of vaping.
Regulators and government have created a “chaotic hot mess” in the U.S., says Clive Bates, tobacco control policy expert and former Director of Action on Smoking and Health (UK), in today’s episode of RegWatch. [...]

October 20, 2022 by filtermag.org

On October 18, the Food and Drug Administration (FDA) and the Department of Justice (DOJ) announced that they had filed for permanent injunctions against six small vape manufacturers in the United States.

Those companies include E-Cig Crib in Minnesota, Soul Vapor in West Virginia, Vapor Craft in Georgia,  Super Vape’z in Washington, Lucky’s Vape & Smoke Shop in Kansas and Butt Out in Arizona. None of them, according to the FDA, submitted premarket tobacco product applications (PMTAs)—an expensive and labor-intensive process that required vape producers to show their products would be more likely to help adults switch from cigarettes to safer alternatives than introduce a new generation to nicotine.

October 20, 2022 by bcm.edu

According to a report published by the Centers for Disease Control, teen vaping rates are on the rise—again. [...] Experts say what is more alarming is that more than one in four students use e-cigarettes daily. Dr. Ramiro Fernandez, assistant professor in the Michael E. DeBakey Department of Surgery – David J. Sugarbaker Division of Thoracic Surgery at Baylor College of Medicine, says that although we don’t have a lot of data on long-term effects of vaping, we do know there is acute lung injury associated with it called EVALI or e-cigarette, or vaping, product use-associated lung injury.

October 19, 2022 by cnn.com

The US Department of Justice took legal action against six e-cigarette manufacturers Tuesday, seeking permanent injunctions against the manufacturers on behalf of the US Food and Drug Administration. The flurry of complaints marked the first time the FDA has taken this step against e-cigarette manufacturers to enforce its premarket review requirements for new tobacco products. The six manufacturers failed to submit the necessary premarket applications for their e-cigarette products “and have continued to illegally manufacture, sell, and distribute their products, despite previous warning from the FDA that they were in violation of the law,” the FDA said in a statement.

October 19, 2022 by filtermag.org

On October 6, the day the Centers for Disease Control and Prevention (CDC) released new data showing a modest uptick in youth vaping amid a longer-term decline, the Food and Drug Administration (FDA) made an announcement of its own. The agency said it had issued marketing denial orders (MDOs) for 32 disposable vaping products through its premarket tobacco product application (PMTA) process—all of them manufactured by Magellan Technology, Inc. and sold under the popular Hyde brand. Many tobacco harm reduction proponents interpreted this as a fairly transparent move by the FDA to appear to be doing something, assuming the new data would be sure to set off the prohibitionist camp. [...]